Long-Term Follow-Up of the Imatinib GRAAPH-2003 Study in Newly Diagnosed Patients with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A GRAALL Study
Aline Schmidt(Hôpital Necker-Enfants Malades), Xavier Thomas(Hôpital Lyon Sud), Françoise Huguet(Centre Hospitalier Universitaire de Toulouse), Norbert Ifrah(Institut National du Cancer), Marie‐Christiane Vekemans(Cliniques Universitaires Saint-Luc), Jean‐Yves Cahn, Philippe Rousselot(Université Paris-Saclay), Delphine Réa(Institut Bergonié), Yves Chalandon(University of Geneva), Jean‐Michel Cayuela(Inserm), Sandrine Hayette(Hôpital Claude Huriez), Jean‐Paul Vernant(Hôpital Saint-Jacques), Martine Escoffre(Institute Cancer De La Loire Lucien Neuwirth), André Delannoy(Hôpital Saint-Jacques), Hervé Dombret(University of London Institute in Paris)
Cited by 149
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k